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Abstract  
Arterial stiffness is one of the biggest predictors of coronary heart disease (CHD). We 
evaluated whether brachial-ankle pulse wave velocity (baPWV) and augmentation index (AI) are 
correlated with risk factors of CHD. All of the 528 participants (270 males and 258 females) of this 
study were healthy workers aged from 36 to 69 (mean age: 47.9±8.1 years). The Framingham Risk 
Score (FRS) showed a good correlation with baPWV (r=0.53, p<0.01), indicating that FRS is 
applicable as an index of arterial stiffness also in Japanese. Blood pressures were well controlled in 
patients with medical treatment for hypertension; however, vessels remained relatively still stiff, 
while the AI was considerably low. Multivariate linear regression analysis showed that factors of 
such as FRS, body mass index, alcohol consumption, and AI P75 were significantly correlated with 
baPWV.  (134 words) 
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Introduction 
Hypertension, hypercholesterolemia and smoking are the three biggest risk factors of 
coronary heart disease (CHD) according to the Framingham Study. Additionally, the 
Framingham Risk Score (FRS) was developed to predict the 10-year risk of CHD in a 
person aged 30-74 years without atherosclerotic CHD (1,2). It is uncertain whether 
FRS is also applicable to Japanese, because it is based on Euro-American data. 
Mortality from CHD in Japan is considerably lower than Euro-American countries. 
Studies are needed to assess whether FRS can predict the risk of CHD also in Japanese.  
At present, the three most common causes of death in Japan are cancer, heart disease, 
and stroke, leading to 273.5, 143.7 and 97.2 deaths per 100,000 person years, 
respectively, according to data compiled by The Health, Labour and Welfare 
Ministry, on the Population Survey Report 2009 Japan (3). The prevention of 
these diseases is the most important issue in public health in Japan as well as the rest of 
the world.  
These risk factors of CHD such as age, blood pressure, serum cholesterol, diabetes 
mellitus and obesity are also risk factors of arterial stiffness. Arterial stiffness is 
associated with a number of deleterious cardiovascular conditions and has been 
identified as an independent risk factor for CHD. 
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Although pulse wave velocity (PWV) of the aorta is being used as the standard measure 
for arterial stiffness in Western countries, it can be measured in some other arterial 
regions, such as heart-carotid (hc), heart-brachial (hb), and femoral-ankle (fa) segments.  
The most frequently studied index to date among a variety of PWV measures is the 
carotid-femoral pulse wave velocity (cfPWV). 
In Japan and other Asian countries, the brachial-ankle PWV (baPWV) is now widely 
utilized, because it can be measured easily and noninvasively.  The baPWV is 
applicable as an indicator of arterial stiffness, which is the case in cfPWV (4). 




This was a sub-analysis of data of the Japan Multi-institutional Collaborative Cohort 
(J-MICC) Study in Kyoto conducted by Kyoto Prefectural University of Medicine. All 
of the 528 participants (270 males and 258 females) of this study were general healthy 
workers of local government offices and companies aged from 36 to 69 and inhabitants 
of Kyoto Prefecture.  Those whose residential addresses were not in Kyoto Prefecture 
were excluded from this study, because of epidemiological follow-up research.  They 
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participated in this study after receiving an adequate explanation of the study and 
signing an informed consent form at a routine annual health check in their workplaces. 
The present study was conducted from July to December 2009.  Measurements of 
blood pressure, baPWV and augmentation index (AI) were conducted after the subjects 
had rested in the siting position for at least five minutes in the morning, and subjects 
were not allowed to smoke before the measurement. All measurements were conducted 
on the annual health check in the work place of the participants.  Each of baPWV 
(S.M.) and AI (E.O.) measurements was done by the same investigators. After the 
completion all measurements, each participant got a detailed briefing on the results from 
a physician. This study consisted of subjects with a health check including serum and 
urine examinations, questionnaire, and blood pressure, baPWV and AI as original items 
of the Kyoto survey.  This study was approved by the ethics committee of Kyoto 
Prefectural University of Medicine (E-267). 
 
J-MICC Study 
The J-MICC Study is a cohort study that was started in 2005 to examine 
gene–environment interactions in lifestyle-related diseases, especially cancers (5). This 
study was supported by a research grant for Scientific Research on Special Priority 
7 
Determinants of baPWV   Mitani S 
Areas of Cancer from the Japanese Ministry of Education, Culture, Sports, Science and 
Technology (6, 7). The J-MICC Study group is composed of 10 cohorts surveyed by 10 
independent research teams (8, 9). Kyoto Prefectural University of Medicine is one of 
these 10 independent research teams. The participants of the J-MICC Study completed 
questionnaire on lifestyle factors and diseases, donated blood samples, and, in addition, 
underwent an examinations of blood pressure, PWV and AI at the time of the baseline 
survey.  
 
baPWV measurement  
baPWV was measured using a volume-plethysmographic apparatus (Form/ABI: 
Omron-Colin, Kyoto, Japan).  
 
Measurements of blood pressure and AI  
The blood pressure was determined by a single measurement on the right upper arm 
using the oscillometric method. Immediately after the measurement, the waveform of 
the left radial artery was recorded for determining AI using an arterial applanation 
tonometry probe incorporating an array of 40 micropiezo-resistive transducers 
(HEM-9000AI: Omron-Colin, Kyoto, Japan). 
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Definition 
Alcohol consumption was classified into two categories depending on the current status, 
current drinker and no-drinker, because former-drinkers were few. 
The smoking status was classified into three categories of current, former, and never 
smoked.  Physical exercise was classified into three categories: one who did not have 
exercise habit, one who exercised one to three times a month, and one who exercised 
more than three times a month.  The categories of hypertension were classified 
according to the staging criterion of the Hypertension Guidelines by the Japanese 
Society of Hypertension Committee (10): optimum BP as SBP<120mmHg and diastolic 
blood pressure (DBP) <80mmHg, normal BP as 120mmHg=< SBP =<139mmHg and 
80mmHg=<DBP=<89mmHg, untreated hypertension as systolic SBP >=140 mmHg and 
/or diastolic DBP >=90mmHg, and treated hypertension.  
Because the observed AI data are influenced by the heart rate, AI P75 was calculated by 
setting the heart rate at 75 beats/min for the heart rate compensation.  
 
Framingham risk score 
The experience of the Framingham study population was used to develop an algorithm 
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that resulted in a calculated score to predict the 10-year risk of CHD. We calculated the 
score from the age, sex, smoking status, blood level of total cholesterol (T-Ch), 




All data is expressed as the mean . Categorical variables are expressed as a 
percentage. Pearson’s correlation coefficients were used to assess the linear relationship 
between baPWV and age, SBP, DBP, T-Ch, triglycerides (TG), HDL-Ch, HbA1c, AI 
P75, body mass index (BMI), and FRS. Differences in each variable between any two 
groups were evaluated using the t-test. Covariance analysis was also performed to 
analyze associations of categorized classifications such as alcohol consumption, 
smoking status, exercise habit, presence of parents’ CHD events, and status of 
hypertension, only in a case in which it was possible to hypothesize parallelism, after 
assessing the absence of an interaction between each factor and covariates (age and sex). 
Multiple regression models were used to analyze associations between baPWV and 
other clinical parameters. P-values less than 0.05 was taken as statistically significant. 
Analyses were performed using SPSS software package 18 (SPSS, Chicago, IL, USA). 
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Results 
Table 1 shows the characteristics of this study population. The mean age of the subjects 
was 47.9±8.1 (male: 47.7±8.5, female: 48.1±7.8) years. There were significant 
differences between males and females, with respect to the height, SBP, DBP, T-ch, TG, 
HDL-ch, AI P75, baPWV and FRS. Males generally had a poor cardiovascular risk 
profile compared to females, characterized by a higher BP, higher T-Ch and lower 
HDL-Ch, higher TG, higher baPWV, higher BMI, and higher FRS. baPWV had a strong 
correlation with the age (r=0.51), SBP (r=0.65), DBP (r=0.66), and FRS (r=0.53), and a 
weak correlation with TG (r=0.30), BMI (r=0.28) and AI P75 (r=0.26). (Table 2) 
Fig.1 reveals that baPWV was significantly correlated with FRS (total: r=0.53, p<0.01, 
for male: r=0.40, p<0.01, for female: r=0.65, p<0.01).   
Covariance analysis showed the relations among baPWV, AI P75, alcohol consumption, 
smoking status, exercise habit, presence of parents’ CHD events, and status of 
hypertension (Table 3-a, and 3-b). Regarding baPWV, there were significant differences 
in exercise habit adjusted by age and sex (F=3.55, p=0.03) and the status of 
hypertension adjusted by sex (F=4.09, p=0.04), after assessing the absence of an 
interaction. Those who exercised more than three times a month showed a lower 
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baPWV than those who did one or three times and those who did not have exercise habit 
in subgroup analysis. As for hypertension, there was an interaction between 
hypertension and age; thus, covariance analysis was conducted to compare the 
hypertension status with baPWV using only sex as a covariant. Regarding BP, the BP 
values of those who received treatment (SBP: 136.4mmHg, DBP: 86.7mmHg) were 
lower than those who did not (SBP: 141.7mmHg, DBP: 93.4mmHg).  However, those 
with anti-hypertensive treatment showed a higher baPWV than the others. (Table 3-a) 
On the other hand, regarding AI P75, there were significant differences in alcohol 
consumption (F=12.9, p<0.01), smoking status (F=7.20, p<0.01) and the status of 
hypertension (F=5.67, p<0.01). Those who were current drinkers and those who had 
never smoked showed a significantly lower AI P75. Those with hypertension without 
treatment showed a higher AI P75 than those with an optimum and normal BP; however, 
there were no significant differences between those with anti-hypertensive treatment 
and the others. Those whose parents had experienced CHD events were 139 persons, 
those whose parents had experienced no events were 305 persons, and those who did 
not know comprised 88 persons. Regarding both baPWV and AI P75, there were no 
significant differences between the presence and absence of parents’ CHD events. 
(Table 3-b) 
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We conducted multivariate linear regression analysis with FRS, BMI, AI P75, alcohol 
consumption, exercise habit and presence of parents’ CHD events. All of the variables 
were involved, because no correlation coefficient of a variable was over 0.9 after 
checking a correlation matrix table. The results of multivariable linear regression 
stepwise analysis are shown in Table 4. The result of ANOVA was significant, and R
2
 
was 0.33. The Durbin-Watson ratio was 2.06, and there was no separate predictive value 
over ±3D against the actual observed value. Thus, factors of FRS, BMI, alcohol 
consumption and AI P75 were related to baPWV.  
 
Discussion 
The Korean data which has the same Asian population with Japanese reported that 
cfPWV was associated with the CVD risk as represented by FRS (r＝0.417、p＜0.01) 
(11). Tanaka et al. also reported that baPWV and cfPWV were closely associated with 
blood pressure, FRS and pre-existing CHD in Japanese.  In their researches, the 
correlation coefficient of baPWV and FRS (r=0.63) was higher than that of cfPWV and 
FRS (r=0.48). (12)  Many previous studies reported a correlation between baPWV and 
FRS, and our study also confirmed this. The stiffness of vessels showed by baPWV had 
a good correlation with lifestyle parameters being risk factors showed by FRS.  
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However, only FRS did not determine the stiffness of vessels.  There were a lot of 
relative factors on baPWV showed in Table 2.  It was a fact that FRS shows a strong 
correlation with baPWV, however, age, gender and BP tended to be stronger factors 
correlated with baPWV.  Although diabetes was reported to be an evident factor of 
CHD and stroke in NIPPON DATA (13), our study showed that there was no 
statistically significant correlation between HbA1c and baPWV (r=-0.03, p=ns).   Our 
data was an accurate assessment regarding the correlation between the abnormal 
glucose tolerance and the stiffness of vessels, while NIPPON DATA addressed the 
mortality and occasional blood glucose level. On the other hand, another study reported 
that diabetes mellitus had a significant correlation with baPWV (14). Thus, further 
research will be needed to clarify the relation between diabetes and baPWV.   
Covariance analysis showed conflicting results regarding alcohol consumption and 
smoking between baPWV and AI P75. Although baPWV reflects the stiffness of vessels, 
AI does the ratio between reflected and ejected waves (15). The bigger a reflected wave, 
and the shorter the returning time of a reflected wave, the bigger the value of AI. AI 
denotes systolic overload of the left ventricle (impedance).   
In the presence study, smoking status and alcohol consumption affected not baPWV but 
AI 75.  Current drinker and never-smoker revealed significantly milder overload of the 
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left ventricle than their counterparts. However, multivariate linear regression analysis 
showed a significant effect of alcohol consumption on baPWV, which is interpreted by a 
fact that beverages provide protection against an oxidative stress in blood vessels and 
decrease arterial stiffness (16). 
Although our study did not analyze the intensity and kind of exercise, our results 
showed that exercise with high frequency made blood vessels smoother, and reduced the 
overload for heart.  It has been shown that regular aerobic exercise is associated with 
reduction in CHD morbidity and mortality (17). Several studies have also shown that 
aerobic exercise improves endothelium-dependent vasodilation (18).  Another study 
has revealed that moderate aerobic exercise reduces endothelin-1-mediated 
vasoconstrictor tone (19). These mechanisms allow vessels to be smoother by aerobic 
exercise. Indeed, some studies reported that exercise caused cfPWV reduction in 
patients with hypertension (20). Our study supported these findings in a healthy 
Japanese population. 
On the other hand, history of parents’ CHD is also reported to be a risk factor of CHD in 
the USA. Some epidemiological studies including prospective studies reported that the 
family history was independent of other risk factors (21, 22). However, our results were 
disagreement with above mentioned findings. This may be explained, at least in part, by 
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the fact that questionnaire was badly-phrased one, or general participants could not 
remember the history of their parents’ diseases.  
More noteworthy was influence of hypertension. The blood vessels of those who had 
anti-hypertensive treatment indeed were stiffer as shown in table Ⅲ-a, however, the 
overload for heart were lower than those who did not have treatment as shown in table
Ⅲ-b showed.   
The difference between arterial stiffness and AI75 may be explained as follows.  
It is assumed that arterial stiffness is determined by pathological characteristics of large 
conductance arteries which seem to be stable for a long period regardless of 
anti-hypertension treatment. In contrast, AI75 is influenced by peripheral arterial tone 
which is sensitive to anti-hypertensive treatment. 
These findings suggest that treatment for hypertension is probably useful to prevent the occurrence 
of CHD. Some previous studies have demonstrated that hypertension is an independent 
risk factor of CHD even when adjusted by other factors. A dose-response relationship, 
whereby an increased BP is associated with an increased risk of the development of 
CHD, could be realized. The Hisayamacho study, which is one of the most famous 
epidemiological studies in Japan, reported that the extent of arterial stiffness was 
significantly correlated with SBP of both the start of the study and just prior to death 
(23).  
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However, there may be some complicated mechanisms regarding how increased SBP 
leads to CHD occurrence in Japanese. Hirai Y, et al. reported that SBP is used to predict 
cardiovascular mortality in a farming but not in a fishing community in a 40-year follow 
up of Japanese cohorts in the Seven Countries Study (24).   
Additionally, baPWV had relation with not only FRS but also BMI, alcohol 
consumption, and AI75 as shown in table Ⅳ. The Framingham study reported that 
obesity was an independent risk factor compared with age, smoking status, total 
cholesterol levels, SBP, diabetes mellitus and cardiomegaly from their 26-year 
investigation (25). Although there are numerous studies indicating the correlation 
between obesity and CHD, FRS does not include the factor of obesity. Our study 
indicated that BMI was an independent risk factor for arterial stiffness.  
 
Conclusions 
 1) The FRS and baPWV show a good correlation. FRS seems to be applicable as an 
index of arterial stiffness also in Japanese. 
2) Blood pressure in patients with anti-hypertensive treatment is well controlled; 
however, vessels are still stiff, whereas the AI is considerably low. These findings 
suggest that anti-hypertensive treatment is probably useful to prevent CHD. 
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Closed circle means male, cross means female.  The dotted line means male (r=0.40), dashed-dotted line means female 
(r=0.65), and continuous line means total of male and female (r=0.53).   





 Table Ⅰ. Characteristics of the participants 
 
 Total  Male  Female  t  P value 
Total number of subjects (%) 528 270 (51.1) 258(48.9)   
Age (years) 47.9±8.1 47.7±8.5 48.1±7.8 0.54 0.59 
Height (cm) 163.7±9.0 170.4±5.7 156.6±5.7 27.64 <0.01 
SBP (mmHg) 120±16 127±15 115±16 7.73 <0.01 
DBP (mmHg) 74±11 78±11 70±11 7.59 <0.01 
T-ch (mg/dL)  204±36 198±37 210±35 2.88 <0.01 
TG  (mg/dL) 106±64 129±67 88±55 7.09 <0.01 
HDL-ch  (mg/dL) 64±16 57±14 69±16 8.95 <0.01 
HbA1c (%) 5.0±0.5 5.0±0.6 5.1±0.5 1.31 0.19 
HR (beats/min) 66±11 67±11 66±11 0.14 0.89 
AI P75 72.4±14.4 66.7±13.6 78.3±12.6 10.10 <0.01 
baPWV (cm/sec) 1,305±230 1,367±220 1,243±14 6.40 <0.01 
BMI (kg/m
2
) 22.5±2.9 23.4±2.8 21.6±2.8 7.34 <0.01 
FRS 10.9±6.5 11.4±6.0 10.5±6.8 1.21 <0.01 
 
SBP: systolic blood pressure 
DBP: diastolic blood pressure 
T-ch: total cholesterol 
TG: triglyceride 
HDL-ch: high-density lipoprotein cholesterol 
HR: heart rate 
AI P75: augmentation index pulse 75 
baPWV: brachial-ankle pulse wave velocity  
BMI: body mass index 
FRS: Framingham risk score 














**: p<0.01, *: p<0.05 
 
 Age  SBP DBP TG T-ch HDL-ch HbA1c AI P75 BMI FRS 
baPWV 0.51** 0.65** 0.66** 0.30* 0.08  -0.16* -0.03  0.26* 0.28* 0.53** 
Age   0.27* 0.26* 0.14* 0.18* -0.07  0.04  0.41* 0.11* 0.81* 
SBP   0.80* 0.30* 0.03  -0.19* -0.16* 0.15* 0.40* 0.37* 
DBP    0.29* 0.08  -0.17* -0.08  0.19* 0.37* 0.35* 
TG     0.15* -0.48* -0.17* -0.05  0.40* 0.31* 
T-ch      0.24* 0.08  0.12* 0.09  0.55* 
HDL-ch       0.08  0.14* -0.40* -0.12* 
HbA1c        0.18* -0.05  0.05  
AI P75         -0.10* 0.36* 
BMI                   0.28* 
Table Ⅲ-a. Covariance analysis of baPWV adjusted by age and sex 
 
    N (%) Estimated baPWV  Adjusted ｂｙ F value P-value 
Alcohol consumption      
 Current drinker 310 (58.4) 1,308±11  Age and sex 0.05 0.82 
 No-drinker／past-drinker 221 (41.6) 1,304±13    
Smoking       
 Current smoker 108 (20.3) 1,316±20  Age and sex 0.22 0.81 
 Former smoker 90 (16.9) 1,314±21    
 Never 333 (62.7) 1,302±11    
Physical exercise       
  Nothing 111 (20.9) 1,349±18 Age and sex 3.55 0.03 
 1-3 times/month 120 (22.6) 1,303±17    
 More  301 (56.6) 1,292±11    
Presence of parents' CVD event      
 Yes 139 (26.1) 1,320±16 Age and sex 0.55 0.58 
 No 305 (57.3) 1,303±11    
 Unknown 88 (16.5) 1,296±21    
Hypertension      
 Optimum BP 204 (38.3) 1,153±13 Sex  4.09 0.04 








50 (9.4) 1,537±25       




 Table Ⅲ-b. Covariance analysis of AI adjusted by age and sex 
 
    N (%) Estimated AI75 Adjusted ｂｙ F value P-value 
Alcoholl consumption      
 Current drinker 306 70.7±15.1  Age  12.9 ＜0.01 
 No-drinker／past-drinker 219 74.6±13.2    
Smoking       
 Current smoker 108 (20.3) 76.6±1.2  Age and sex 7.20 ＜0.01 
 Former smoker 90 (16.9) 72.4±1.3    
 Never 333 (62.7) 71.0±0.7    
Physical exercise       
  Nothing 110 74.3±1.2  Age and sex 1.87 0.16 
 1-3 times/month 118 72.7±1.1    
 More 298 71.6±0.7    
Presence of parents' CVD event      
 Yes 139 72.0±1.0 Age and sex 0.37 0.69 
 No 305 72.4±0.7    
 Unknown 84 73.4±1.3    
Hypertension      
 Optimum BP 202 70.1±0.9 Age and sex 5.67 <0.01 








50 72.8±1.7       
       
 







p-value 95% CI 
Invariable  694.86  119.10  <0.01 460.51  929.22  
FRS 15.88  2.01  <0.01 11.93  19.83  
BMI 14.48  4.11  <0.01 6.41  22.56  
Alcohol  -33.30  11.42  <0.01 -55.78  -10.83  
AI P75 2.44  0.87  <0.01 0.74  4.15  
 
CI: confidence interval 
Abbreviations are same as in Table Ⅰ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
